Cost of revenue · 2015–2025
AstraZeneca cost of revenue
$10.6B+4.2% · FY2025
AstraZeneca (AZN) reported $10.6B in cost of revenue for fiscal 2025, +4.2% year on year.
| Fiscal year | Cost of revenue | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $10.6B | +4.2% | Open → |
| FY20242024-12-31 | $10.2B | +23.5% | Open → |
| FY20232023-12-31 | $8.3B | −33.3% | Open → |
| FY20222022-12-31 | $12.4B | −0.4% | Open → |
| FY20212021-12-31 | $12.4B | +134.7% | Open → |
| FY20202020-12-31 | $5.3B | +7.7% | Open → |
| FY20192019-12-31 | $4.9B | −0.3% | Open → |
| FY20182018-12-31 | $4.9B | +14.3% | Open → |
| FY20172017-12-31 | $4.3B | +4.7% | Open → |
| FY20162016-12-31 | $4.1B | −11.2% | Open → |
| FY20152015-12-31 | $4.6B | — | Open → |
Cost of revenue — Cost of revenue is the direct cost of producing what the company sold — materials, manufacturing and the labour tied to delivery. It excludes sales, marketing and administration. Revenue minus this figure is gross profit.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2015–2025 compound annual growth +8.6%
Figures are reported under IFRS, in US dollars.
Cost of revenue at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=AstraZeneca cost of revenue |url=https://companiesranked.com/en/company/astrazeneca/cost-of-revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). AstraZeneca cost of revenue. CompaniesRanked. https://companiesranked.com/en/company/astrazeneca/cost-of-revenueBibTeX
@misc{companiesranked-en-company-astrazeneca-cost-of-revenue-2026,
author = {{CompaniesRanked}},
title = {{AstraZeneca cost of revenue}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/astrazeneca/cost-of-revenue}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001104659-26-019130 · February 24, 2026
{{cite web |title=AstraZeneca cost of revenue — 20-F (0001104659-26-019130) |url=https://www.sec.gov/Archives/edgar/data/901832/000110465926019130/azn-20251231x20f.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-24}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.